Back

Atomic IBD

Substack
atomicibd.com· weekly· Published yesterday

A UK-based IBD clinician-writer reviews clinical trial and guideline developments such as the VERDICT ulcerative colitis treatment-target trial and STRIDE-III, and offers historical pieces on the origins of IBD diagnosis. The newsletter also includes personal reflections on using AI tools for thinking and writing.

inflammatory bowel diseaseulcerative colitiscrohn's diseasetreat to targetverdict trialstride-iiivedolizumabibd historymedical historyai writing toolsclinical trialsgastroenterology
Platform
Substack
Frequency
Weekly
Latest issue
Oct 24, 2026
Language
English
Written for
Gastroenterologists, IBD clinicians and nurses, and patients following IBD research
Tone
conversational
Tracked since
Oct 25, 2026

Website: https://www.atomicibd.com